OBIO News Guest User OBIO News Guest User

PreCAAP Company: iamsick.ca featured in StartUp Here TORONTO

Stay Away from Me...I Am Sick

OBIO Pre-CAAP Company iamsick.ca knows that the last thing you want to do when you are sick is look for a family doctor, a walk-in-clinic or a nearby pharmacy.  The new app informs patients on what clinics are nearby (in your actual area) and pharmacies and to find out what clinics are accepting new patients (great when you move to a new area!) and book appointments online.

For the full article click here

Read More
OBIO News Guest User OBIO News Guest User

CAAP Company: Eve Medical's Eve Kit Highlighted on CBC News

Former OBIO CAAP company Eve Medical was highlighted on CBC News. The EVE Kit is gearing up to be ready for purchase online this fall!

"Canadian women may be able to self-administer tests for sexually transmitted infections from the comfort of their own homes, for less than $100." 

CEO Jessica Ching says, the hope is to make "it more convenient for women to test for HPV which could guard against cervical cancer."

Follow their progress and updates on Twitter @evemedical

For the CBC feature click here

Read More
OBIO News Guest User OBIO News Guest User

Pre-CAAP: Winterlight Labs, SensOR Medical Laboratory, TopSpin360, iMerciv - Winners of 2016 ONtrepreneurs Program

Aug 8, 2016 - 4 OBIO Pre-CAAP companies have been selected as winners of the Ontario Brain Institute (OBI) 2016 ONtrepreneurs Program!

Congratulations to  Winterlight Labs, SensOR Medical Laboratory, TopSpin360 & iMerciv!

The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program helps "Ontario neurotech entrepreneurs take their ideas from the lab to the marketplace."

This year's winners participated in a pitching competition to a panel of "expert judges from organizations including Yocto Law, Biomedical Zone, Emmetros, AGE-WELL, Ironstone Product Development Inc. and OBI."

$300,000 ($50,000 each) has been awarded to the winners to assist with commercializing their neurotechnologies.

For the full press release, click here

 

Read More
OBIO News Guest User OBIO News Guest User

CAAP Company: CellAegis' autoRIC® Device Clinically Implemented in Peel-Halton Region

CellAegis autoRIC® Device, which reduces heart damage in ischemic heart disease, is now being clinically implemented in Peel-Halton Region, West of Toronto. The autoRIC® Device is being used to treat all patients having heart attacks, in addition to standard treatment. The FIRST study (Field Implementation of autoRIC Device in STEMI (ST-segment Myocardial Infarction)) is the first clinical implementation of our device across an entire region, and is expected to be the first of many such clinical implementations, as the benefit of Remote Ischemic Conditioning therapy becomes more widely utilized.

For the full press release click here

Read More
OBIO News Guest User OBIO News Guest User

CAAP Company: KA Imaging Receives $1M to develop low-cost lung screening

July 21, 2016 KITCHENER — A startup developing a low-cost, high-resolution digital X-ray imager to detect lung disease in developing nations has received a $1-million boost.

The new money from federally funded Grand Challenges Canada will help KA Imaging build a prototype and test it in the field in Zambia by the end of the year.

For the full article click here

For the Grand Challenges press release, click here

Read More
OBIO News Guest User OBIO News Guest User

OBIO Innovation Agenda Leader

OBIO Innovation Agenda Leader

On July 21st, Gail Garland, CEO of OBIO attended the  Federal Government's Global Science Excellence Roundtable, part of the Inclusive Innovation Agenda Strategy held in Ottawa.

The ideas generated during the session will be consolidated and presented to Minister Navdeep Bains for consideration as part of the Inclusive Innovation Agenda report.

For the full report, click here

For the Innovation Submission page, click here

Read More
OBIO News Guest User OBIO News Guest User

CAAP Company: iTP Biomedica Launches BladderPredict, A State-Of-The-Art Diagnostic To Manage Early Stage Bladder Cancer

July 19, 2016 TORONTO – iTP Biomedica Corp., a developer of proprietary whole transcriptome-based cancer diagnostics, today announced the launch of BladderPredict, a groundbreaking next-generation sequencing-based test that will for the first time assist uro-pathologists in assigning disease grade in early stage bladder cancer, and urologists and uro-oncologists in managing the disease.

For the full press release, click here

Read More
OBIO News Guest User OBIO News Guest User

RESI Toronto Receives Two Thumbs Up

June 24, 2016 This year Toronto hosted the inaugural RESI conference on June 23, bringing together hundreds of companies and investors from across the globe in areas of biotech, digital health, medical devices and consumer health. 

Read More

OBIO CAAP Company: Anges Québec members contribute to $530,000 investment in Ovensa

June 8th, 2016 Montreal – Today Anges Québec announced its members are taking a stake in Ovensa,
a biotechnology company. Members of Anges Québec and Aligo Innovation are joining with private investors to inject $530,000 into this Ontario firm, whose new technology delivers therapeutic molecules through oral administration to targeted human tissue, including the brain—a major medical advance.

For the full press release, click here 

Read More
OBIO News Guest User OBIO News Guest User

CAAP Company: MEDELLA HEALTH Raises $1.4 MILLION

June 2, 2016 Harry Gandhi is the co-founder of Medella Health, a Waterloo-based company developing a smart contact lens that continuously monitors glucose levels (with the information transmitted to a mobile device), is hoping that its contact lens will change the way we approach the disease. The company has raised $1.4 million in funding from 1517 Fund, Fifty Years Fund, Garage Capital, and BDC Capital.

For the full story, click here

Read More
Ontario Industry Updates, OBIO News Guest User Ontario Industry Updates, OBIO News Guest User

OBIO CAAP Company: Perimeter Medical Imaging Receives FDA Clearance for OTIS Optical Tissue Imaging System

May 24, 2016  TORONTO Perimeter Medical Imaging, Inc., an innovative medical imaging company whose mission is to revolutionize tissue removal surgery for surgeons and patients, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its OTISTM 1.0 Optical Coherence Tomography System.

For the full press release, click here

Read More
OBIO News Guest User OBIO News Guest User

Johnson & Johnson Innovation Opens JLABS @ Toronto

TORONTO, May 11, 2016 Johnson & Johnson Innovation announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they work to build important and successful early-stage companies.

Read More